The MoUs signed separately by the Department of Biotechnology (DBT) and the Department of Science and Technology (DST) with RIKEN, a Japanese multidisciplinary research organisation, are expected to help research in the fields of biology, life sciences, material sciences and computational sciences.
Speaking at the event, Noyori Ryogi, President of RIKEN and a Nobel Laureate, said "with these MOUs, we look forward to seeing lively discussions with Indian scientists and work together."
T Madhan Mohan, Advisor in the DBT, said "there can be exchange of information in research and development and exchange of scientists. Further, students can seek doctoral and post-doctoral fellowships ."
"A huge foundation of interaction is already there in field of cell and developmental biology with the NCBS and material sciences with the JNCASR. These MOUs will allow researchers to work in a seamless manner," said Dr K Vijay Raghvan, secretary DBT.
Taking the collaboration forward, the Ministry of Science and Technology of the both the countries have decided to have direct interactions.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
